Cleared Traditional

K042982 - QUANTEX MYOGLOBIN (FDA 510(k) Clearance)

Dec 2004
Decision
54d
Days
Class 2
Risk

K042982 is an FDA 510(k) clearance for the QUANTEX MYOGLOBIN. This device is classified as a Myoglobin, Antigen, Antiserum, Control (Class II - Special Controls, product code DDR).

Submitted by Instrumentation Laboratory CO (Bedford, US). The FDA issued a Cleared decision on December 22, 2004, 54 days after receiving the submission on October 29, 2004.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 866.5680.

Submission Details

510(k) Number K042982 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 29, 2004
Decision Date December 22, 2004
Days to Decision 54 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code DDR — Myoglobin, Antigen, Antiserum, Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5680